Efficacy and Safety of Insulin Degludec/Insulin Aspart Compared with a Conventional Premixed Insulin or Basal Insulin: A Meta-Analysis

Insulin degludec/insulin aspart (IDegAsp) is a novel co-formulation of 70% insulin degludec and 30% insulin aspart. The present meta-analysis was conducted to assess the efficacy and safety of IDegAsp compared with a conventional premixed insulin or basal insulin. We extracted data from citation dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Shinje, Chung, Hye-Soo, Kim, Yoon-Jung, Yu, Jae-Myung, Jeong, Woo-Ju, Park, Jiwon, Oh, Chang-Myung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470485/
https://www.ncbi.nlm.nih.gov/pubmed/34564455
http://dx.doi.org/10.3390/metabo11090639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470485/
https://www.ncbi.nlm.nih.gov/pubmed/34564455
http://dx.doi.org/10.3390/metabo11090639

Ejemplares similares